Sodium Acetate Injection

• • Sodium acetate injection, Fresenius Kabi, 4 mEq/mL, 100 mL vial, 20 count, NDC 63323-0032-00
  • Sodium acetate injection, Pfizer, 2 mEq/mL, 100 mL vial, 25 count, NDC 00409-3299-06
  • Sodium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-7299-73
  • Sodium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3299-05

• • Fresenius Kabi has sodium acetate injection on shortage due to increased demand.
  • Pfizer has sodium acetate injection on shortage due to production delays from a component of a third-party supplier.
  • Woodward Pharma did not provide a reason for the shortage.

• • Sodium acetate injection, Woodward, 2 mEq/mL, 100 mL vial, 1 count, NDC 69784-0231-20
  • Sodium acetate injection, Woodward, 2 mEq/mL, 50 mL vial, 1 count, NDC 69784-0230-20

Estimated Resupply Dates

• • Fresenius Kabi has sodium acetate 4 mEq/mL 100 mL vials on back order and the company cannot estimate a release date.
  • Pfizer has sodium acetate 2 mEq/mL 20 mL, 50 mL, and 100 mL vials on back order and the company estimates a release date of January 2023.